FILE PHOTO: Robert F. Kennedy Jr., U.S. President Trump’s nominee to be secretary of Health and Human Services, testifies before a Senate Health, Education, Labor, and Pensions (HELP) Committee confirmation hearing on Capitol Hill in Washington, U.S., January 30, 2025.Â
Nathan Howard | Reuters
Shares of vaccine companies fell on Tuesday after a Senate panel voted to advance Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services to the full chamber.Â
The committee voted 14 to 13 to advance Kennedy in a party-line vote around 10:30 a.m. ET.
Moderna‘s stock fell about 2% and shares of BioNTech dropped nearly 2%. Shares of Novavax fell more than 2%, while GSK‘s stock dropped slightly. Pfizer‘s stock fell more than 1%, even after the company reported fourth-quarter results that topped expectations. Their shares initially fell by larger margins following the Senate committee vote, then regained some ground….
